Retinoblastoma and vision

[1]  L. Desjardins,et al.  Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome , 2020, Pediatric blood & cancer.

[2]  B. Morland,et al.  Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy , 2020, British Journal of Ophthalmology.

[3]  Dorothy A. Thompson,et al.  VEP estimation of visual acuity: a systematic review , 2020, Documenta Ophthalmologica.

[4]  I. Gottlob,et al.  Management of nystagmus in children: a review of the literature and current practice in UK specialist services , 2020, Eye.

[5]  H. Brisse,et al.  Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis , 2020, Pediatric blood & cancer.

[6]  P. Maeder,et al.  Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity” , 2019, Progress in Retinal and Eye Research.

[7]  Jose J. Echegaray,et al.  Episcleral brachytherapy for retinoblastoma , 2019, British Journal of Ophthalmology.

[8]  G. Rubin,et al.  Microperimetry and swept-source optical coherence tomography in the assessment of the preferred retinal locus in a child with macular retinoblastoma in the remaining eye. , 2019, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[9]  Yuankai K. Tao,et al.  Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach , 2019, Investigative ophthalmology & visual science.

[10]  F. Shawkat,et al.  Supranuclear eye movements and nystagmus in children: A review of the literature and guide to clinical examination, interpretation of findings and age-appropriate norms , 2018, Eye.

[11]  B. Gallie,et al.  Vision and visual potential for perifoveal retinoblastoma after optical coherence tomographic-guided sequential laser photocoagulation , 2018, British Journal of Ophthalmology.

[12]  A. Stacey,et al.  The Incidence of Binocular Visual Impairment and Blindness in Children with Bilateral Retinoblastoma , 2018, Ocular Oncology and Pathology.

[13]  C. Shields,et al.  Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras. , 2018, Ophthalmology.

[14]  M. Sagoo,et al.  Classification and staging of retinoblastoma , 2018, Community eye health.

[15]  C. Shields,et al.  Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists. , 2018, Ophthalmology.

[16]  Z. Onadim,et al.  The management of retinoblastoma , 2018, Oncogene.

[17]  A. Stacey,et al.  Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes. , 2017, American journal of ophthalmology.

[18]  K. Rantell,et al.  Lag time for retinoblastoma in the UK revisited: a retrospective analysis , 2017, BMJ Open.

[19]  A. Stacey,et al.  Focal laser treatment in addition to chemotherapy for retinoblastoma. , 2017, The Cochrane database of systematic reviews.

[20]  B. Gallie,et al.  Optical Coherence Tomography-Guided Decisions in Retinoblastoma Management. , 2017, Ophthalmology.

[21]  A. Stacey,et al.  High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes. , 2017, Ophthalmology.

[22]  Shigenobu Suzuki,et al.  Related visual impairment to mother-infant interaction and development in infants with bilateral retinoblastoma. , 2017, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[23]  Dorothy A. Thompson,et al.  Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma , 2017, British Journal of Ophthalmology.

[24]  B. Gallie,et al.  Genetics and Molecular Diagnostics in Retinoblastoma—An Update , 2017, Asia-Pacific journal of ophthalmology.

[25]  Kenneth P. Johnson,et al.  Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis , 2016, British Journal of Ophthalmology.

[26]  B. Gallie,et al.  Prenatal versus Postnatal Screening for Familial Retinoblastoma. , 2016, Ophthalmology.

[27]  R. Channa,et al.  Intravitreal Chemotherapy for Retinoblastoma , 2016 .

[28]  B. Chawla,et al.  Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study , 2016, Indian journal of ophthalmology.

[29]  B. Gallie,et al.  Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review. , 2016, JAMA ophthalmology.

[30]  E. Hartmann,et al.  Motor skills of children with unilateral visual impairment in the Infant Aphakia Treatment Study , 2016, Developmental medicine and child neurology.

[31]  A. Batra,et al.  Long-term visual outcomes in intraocular retinoblastoma with eye preservation , 2016, Clinical and Translational Oncology.

[32]  C. Shields,et al.  Treatment of Retinoblastoma in 2015: Agreement and Disagreement. , 2015, JAMA ophthalmology.

[33]  Robert J. Ogg,et al.  Spatiotemporal Patterns of Tumor Occurrence in Children with Intraocular Retinoblastoma , 2015, PloS one.

[34]  F. Munier.  Classification and Management of Seeds in RetinoblastomaEllsworth Lecture Ghent August 24th 2013 , 2014, Ophthalmic genetics.

[35]  K. Engelhard,et al.  General anaesthetics and the developing brain: an overview , 2014, Anaesthesia.

[36]  C. Rodríguez-Galindo,et al.  Developmental and adaptive functioning in children with retinoblastoma: a longitudinal investigation. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Niklas Pal,et al.  A 10‐year experience of outcome in chemotherapy‐treated hereditary retinoblastoma , 2014, Acta ophthalmologica.

[38]  Yan Liu,et al.  Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[39]  Jennifer H. Acton,et al.  Fundus-driven perimetry (microperimetry) compared to conventional static automated perimetry: similarities, differences, and clinical applications. , 2013, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[40]  Dorothy A. Thompson,et al.  Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision , 2013, British Journal of Ophthalmology.

[41]  Stephen J. Smith,et al.  Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review , 2013, British Journal of Ophthalmology.

[42]  C. Shields,et al.  Predictors of long‐term visual outcome after chemoreduction for management of intraocular retinoblastoma , 2012, Clinical & experimental ophthalmology.

[43]  S. Brodie,et al.  Intra-arterial chemotherapy for retinoblastoma. , 2012, Ophthalmology.

[44]  C. Shields,et al.  Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma. , 2012, Ophthalmology.

[45]  M. Reddy,et al.  Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. , 2012, Ophthalmology.

[46]  F. Munier,et al.  Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track , 2012, British Journal of Ophthalmology.

[47]  C. Shields.  Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma , 2012 .

[48]  J. O'Brien,et al.  Intra-arterial chemotherapy for advanced retinoblastoma: is the time right for a prospective clinical trial? , 2011, Archives of ophthalmology.

[49]  C. Shields,et al.  Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. , 2011, Archives of ophthalmology.

[50]  A. Kaneko,et al.  Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. , 2011, Ophthalmology.

[51]  M. Paloheimo,et al.  Intravitreal methotrexate for retinoblastoma. , 2011, Ophthalmology.

[52]  E. Peterson,et al.  Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. , 2011, Journal of neurosurgery.

[53]  F. Munier,et al.  OCCURRENCE OF SECTORAL CHOROIDAL OCCLUSIVE VASCULOPATHY AND RETINAL ARTERIOLAR EMBOLIZATION AFTER SUPERSELECTIVE OPHTHALMIC ARTERY CHEMOTHERAPY FOR ADVANCED INTRAOCULAR RETINOBLASTOMA , 2011, Retina.

[54]  Seong-Joon Kim,et al.  Visual Prognosis of Retinoblastoma in the Posterior Pole Treated with Primary Chemotherapy Plus Local Treatments , 2010, Korean journal of ophthalmology : KJO.

[55]  A. Moll,et al.  Restrictions in daily life after retinoblastoma from the perspective of the survivors , 2010, Pediatric blood & cancer.

[56]  L. Pring,et al.  Attentional processes in young children with congenital visual impairment. , 2009, The British journal of developmental psychology.

[57]  C. Shields,et al.  Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors. , 2009, Archives of ophthalmology.

[58]  R. T. Smith,et al.  PREFERRED RETINAL LOCUS IN MACULAR DISEASE: Characteristics and Clinical Implications , 2008, Retina.

[59]  S. Brodie,et al.  A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. , 2008, Ophthalmology.

[60]  S. Brodie,et al.  Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma , 2009, Documenta Ophthalmologica.

[61]  E. Hartman,et al.  Motor skill performance of school‐age children with visual impairments , 2008, Developmental medicine and child neurology.

[62]  A. Moll,et al.  Health-related quality of life of child and adolescent retinoblastoma survivors in the Netherlands , 2007, Health and quality of life outcomes.

[63]  M. Seeliger,et al.  Quantifying fixation in patients with Stargardt disease , 2007, Vision Research.

[64]  E. Marchiori,et al.  Retinoblastoma--comparative analysis of external radiotherapy techniques, including an IMRT technique. , 2007, International journal of radiation oncology, biology, physics.

[65]  Timothy G Murray,et al.  Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. , 2007, Ophthalmology.

[66]  A. Moll,et al.  Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands , 2006, British Journal of Ophthalmology.

[67]  C. Shields,et al.  The International Classification of Retinoblastoma predicts chemoreduction success. , 2006, Ophthalmology.

[68]  M. Tucker,et al.  Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  A. LinnMurphree.  Intraocular retinoblastoma: the case for a new group classification. , 2005 .

[70]  B. Gallie,et al.  Chemotherapy for retinoblastoma. , 2005, Ophthalmology clinics of North America.

[71]  A. Linn Murphree.  Intraocular retinoblastoma: the case for a new group classification. , 2005, Ophthalmology clinics of North America.

[72]  C. Shields,et al.  Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. , 2004, American journal of ophthalmology.

[73]  A. Kaneko,et al.  Management of intraocular retinoblastoma and ocular prognosis , 2004, International Journal of Clinical Oncology.

[74]  M. Sexton,et al.  Retinoblastoma: review of 30 years' experience with external beam radiotherapy. , 2003, Australasian radiology.

[75]  N. Dale,et al.  Developmental outcome, including setback, in young children with severe visual impairment , 2002 .

[76]  L. Desjardins,et al.  Functional results after treatment of retinoblastoma. , 2002, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[77]  D. Gombos,et al.  Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age , 2002, The British journal of ophthalmology.

[78]  B. Gallie,et al.  Visual results in children treated for macular retinoblastoma , 2002, Eye.

[79]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[80]  G. Ross,et al.  The development of young children with retinoblastoma. , 2001, Archives of pediatrics & adolescent medicine.

[81]  J. Hungerford,et al.  Delay in diagnosis of retinoblastoma: risk factors and treatment outcome , 1999, The British journal of ophthalmology.

[82]  D. Abramson,et al.  Visual outcomes in children with bilateral retinoblastoma. , 1999, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[83]  K Simons,et al.  Natural history of amblyopia untreated owing to lack of compliance , 1999, The British journal of ophthalmology.

[84]  T. Murray.  Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. , 1998, Survey of ophthalmology.

[85]  C. Shields,et al.  Radiation therapy for uveal malignant melanoma. , 1998, Ophthalmic surgery and lasers.

[86]  H. Genant,et al.  Agreement and Disagreement , 1997 .

[87]  J. Fraumeni,et al.  Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. , 1997, JAMA.

[88]  S. Madreperla,et al.  Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. , 1996, Archives of ophthalmology.

[89]  S. Lambert,et al.  Reappraisal of occlusion therapy for severe structural abnormalities of the optic disc and macula. , 1995, Journal of pediatric ophthalmology and strabismus.

[90]  A. Weiss,et al.  Visual outcomes of macular retinoblastoma after external beam radiation therapy. , 1994, Ophthalmology.

[91]  J. Zwaan.  INTRAOCULAR TUMORS. A TEXT AND ATLAS , 1993 .

[92]  MORTON E. Smith,et al.  Intraocular Tumors. A Text and Atlas , 1992 .

[93]  T. Losasso,et al.  Radiation therapy for retinoblastoma: comparison of results with lens-sparing versus lateral beam techniques. , 1987, International journal of radiation oncology, biology, physics.

[94]  C. Migdal,et al.  Bilateral retinoblastoma: the prognosis for vision. , 1983, The British journal of ophthalmology.

[95]  R. Ellsworth,et al.  Cryotherapy for retinoblastoma. , 1982, Archives of ophthalmology.

[96]  R. Ellsworth,et al.  External beam radiation for retinoblastoma. , 1981, Bulletin of the New York Academy of Medicine.

[97]  B. Kushner.  Functional amblyopia associated with organic ocular disease. , 1981, American journal of ophthalmology.

[98]  P. B. Marcus,et al.  Retinoblastoma treated by freezing. , 1971, The British journal of ophthalmology.

[99]  B. Rosengren,et al.  PRESENT THERAPEUTIC RESOURCES IN RETINOBLASTOMA , 1961, Acta ophthalmologica.